.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Optimal Treatment for Advanced Colon and Rectal Cancers

EP. 1: Current Role of Adjuvant Therapy for Colon Cancer

November 21st 2018

EP. 2: Efficacy of Adjuvant Therapy in Stage II Colon Cancer

November 21st 2018

EP. 3: Treatment Options for High-Risk Stage II Colon Cancer

November 21st 2018

EP. 4: Optimal Duration of Therapy for Stage III Colon Cancer

November 21st 2018

EP. 5: Maintaining Wellness After Treatment

November 21st 2018

EP. 6: Treating Locally Advanced Rectal Cancer

November 21st 2018

EP. 7: Molecular Testing for Newly Diagnosed mCRC

November 21st 2018

EP. 8: Application of Molecular Testing Results in Treating mCRC

November 21st 2018

EP. 9: Optimal Therapy for BRAF-Mutated mCRC

November 21st 2018

EP. 10: Treatment Options for First- and Second-Line Left-Sided CRC

November 21st 2018

EP. 11: Treatment Options for Right-Sided CRC

November 21st 2018

EP. 12: Sidedness as Drivers of Treatment Decisions in CRC

November 21st 2018

EP. 13: TAS-102 Versus Regorafenib for Treating mCRC

November 21st 2018

EP. 14: Efficacy and Safety of Immunotherapy for mCRC

November 21st 2018

EP. 15: Tumor Mutational Burden in CRC

November 21st 2018